Health
AstraZeneca announces withdrawing COVID-19 vaccine globally
The company says it would proceed to withdraw the vaccine Vaxzevria's marketing authorisations within Europe
(Reuters) - AstraZeneca, opens new tab said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.
The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.
"As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.
According to media, opens new tab reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.
The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.
London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.
-
Regional 2 days ago
Sun shines in Lahore, no chance of rain
-
Business 2 days ago
Gold price dips by Rs600 per tola
-
Business 1 day ago
Prices of gold go extremely high today
-
Pakistan 1 day ago
Shehbaz nominated acting president of PML-N
-
Pakistan 1 day ago
PM directs Amir Muqam to leave for Kyrgyzstan immediately
-
Pakistan 2 days ago
Suo Motu case: CJP seeks response from Vawda, Mustafa
-
Pakistan 2 days ago
Newly elected MNA Ali Pervaiz takes oathÂ
-
World 1 day ago
Riots among students in Kyrgyzstan